Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enzyme (MLN) vs Orchid (OXT) Price & Performance

Price performance (Past 24H)

Key statistics

Enzyme vs Orchid — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Orchid trades at Rp164.34 (market cap Rp190,2M, Rp47,84M 24h volume). The key difference: Orchid is the larger of the two by market cap, and Enzyme's circulating supply is 3,3M MLN versus 997,2M OXT for Orchid. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Orchid for 44 Days on average.

MLNOXT
Market Cap
Rp134,13MRp190,2M
Volume (24h)
Rp104,56MRp47,84M
Circulating Supply
3,3M MLN997,2M OXT
Typical Hold Time
29 Days44 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Orchid

Orchid (OXT) exhibits a very low market capitalization of Rp190.2M, indicating a micro-cap token with limited market presence. The average hold time of 44 days suggests some short-term accumulation, but the absence of a current price and recent price data limits technical trend analysis. No major protocol updates or significant ecosystem developments have been reported recently, pointing to a period of low network activity.

Overall outlook is highly speculative due to the token's small size and low liquidity. The key opportunity lies in potential future protocol adoption, but major risks include extreme volatility, low trading volume, and the inherent fragility of micro-cap assets in the crypto market. Investors should be aware of the high probability of significant price swings.

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN

About Orchid

Orchid describes itself as the world’s first incentivized, peer-to-peer privacy network. Its aim is to overcome internet freedom limitations by using cryptocurrency payments to allow anyone to purchase bandwidth from any participating provider. This is done using so-called probabilistic nanopayments, which occur using OXT, an ERC-20 standard token on Ethereum.

Read more on OXT